Annual Securities Report — FY2025
What MUROMACHI CHEMICALS INC. reported for the period from 2025-06-01 to 2026-05-31.
Filed 2026-08-25View the original on EDINET
How much it says
75Very detailed
What moved here
16named for the first time
Its own wording
57terms
Which filing this is
16/ 16newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
In the fiscal year, revenue, operating profit and ordinary profit increased, while net income decreased because an impairment loss related to the pharmaceutical synthesis business was recorded as an extraordinary loss. The company also completed its exit from the health foods business at the end of the fiscal year ended May 2026 and indicated a policy of concentrating management resources on pharmaceuticals and chemicals.
Komori's summary of this document, not the document's own words.75Very detailed
How much this filing saysA weighted roll-up of 11 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 35 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
96
Very detailed
54
Typical
100
Very detailed
75
Very detailed
100
Very detailed
100
Very detailed
37
Thin
69
Detailed
44
Thin
55
Typical
77
Very detailed
R&D spend32百万円Money spent making new things.
Cash left over6億円Cash from the business, less what went into equipment.
Spent on equipment2億円Plants, machines — things meant to last.
Employees199Headcount at the end of this period.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.